Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study

Aminu K Bello, Paul E Ronksley, Navdeep Tangri, Julia Kurzawa, Mohamed A Osman, Alexander Singer, Allan Grill, Dorothea Nitsch, John A Queenan, James Wick, Cliff Lindeman, Boglarka Soos, Delphine S Tuot, Soroush Shojai, Scott Brimble, Dee Mangin, Neil Drummond, Aminu K Bello, Paul E Ronksley, Navdeep Tangri, Julia Kurzawa, Mohamed A Osman, Alexander Singer, Allan Grill, Dorothea Nitsch, John A Queenan, James Wick, Cliff Lindeman, Boglarka Soos, Delphine S Tuot, Soroush Shojai, Scott Brimble, Dee Mangin, Neil Drummond

Abstract

Introduction: Surveillance systems enable optimal care delivery and appropriate resource allocation, yet Canada lacks a dedicated surveillance system for chronic kidney disease (CKD). Using data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), a national chronic disease surveillance system, this study describes the geographic, sociodemographic, and clinical variations in CKD prevalence in the Canadian primary care context.

Methods: This cross-sectional study included 559,745 adults in primary care in 5 provinces across Canada from 2010 through 2015. Data were analyzed by geographic (urban or rural residence), sociodemographic (age, sex, deprivation index), and clinical (medications prescribed, comorbid conditions) factors, using data from CPCSSN and the Canadian Deprivation Index. CKD stage 3 or higher was defined as 2 estimated glomerular filtration rate (eGFR) values of <60 ml/min per 1.73 m2 more than 90 days apart as of January 1, 2015.

Results: Prevalence of CKD was 71.9 per 1000 individuals and varied by geography, with the highest prevalence in rural settings compared with urban settings (86.2 vs. 68.4 per 1000). CKD was highly prevalent among individuals with 3 or more other chronic diseases (281.7 per 1000). Period prevalence of CKD indicated a slight decline over the study duration, from 53.4 per 1000 in 2010 to 46.5 per 1000 in 2014.

Conclusion: This is the first study to estimate the prevalence of CKD in primary care in Canada at a national level. Results may facilitate further research, prioritization of care, and quality improvement activities to identify gaps and improvement in CKD care.

Keywords: chronic kidney disease (CKD); electronic medical record; epidemiology; prevalence; primary care; surveillance.

Figures

Figure 1
Figure 1
Participation of Canadian Primary Care Sentinel Surveillance Network (CPCSSN) networks by province. Blue, nonparticipating CPCSSN networks; orange, participating CPCSSN networks. Primary care research networks contributing data to the CPCSSN: 1, British Columbia Primary Care Research Network (BCPCReN); 2, Northern Alberta Primary Care Research Network (NAPCReN); 3, Southern Alberta Primary Care Research Network (SAPCReN); 4, Manitoba Primary Care Research Network (MaPCReN); 5, Deliver Primary Healthcare Information Project (DELPHI); 6, McMaster University Sentinel and Information Collaboration (MUSIC); 7, University of Toronto Practice-Based Research Network (UTOPIAN); 8, The Eastern Ontario Network (EON); 9, Ottawa Practice Enhancement Network (OPEN); 10, Réseau de recherche en soins primaires de l’Université de Montréal (RRSPUM); 11, Maritime Family Practice Research Network (MaRNet-FP); 12, Atlantic Practice-Based Research Network (APBRN).
Figure 2
Figure 2
Selection of study population. CPCSSN, Canadian Primary Care Sentinel Surveillance Network; eGFR, estimated glomerular filtration rate; PCP, primary care provider.
Figure 3
Figure 3
(a) Overall prevalence of chronic kidney disease (CKD) (2010–2015) by deprivation index, by CKD stage. Level of deprivation of Canadian Deprivation Index score: 1 (least deprived), dark blue; 2, red; 3, green; 4, purple; 5 (most deprived), light blue. (b) Overall prevalence of CKD (2010–2015) by urban/rural residence, stratified by CKD stage. Participant residence: urban (blue); rural (red).
Figure 4
Figure 4
(a) Period prevalence of chronic kidney disease (CKD) by year and deprivation index. Level of deprivation of Canadian Deprivation Index score: 1 (least deprived), dark blue; 2, red; 3, green; 4, purple; 5 (most deprived), light blue. (b) Period prevalence of CKD by year and urban/rural residence. Participant residence: urban (blue); rural (red).

References

    1. Manns B., McKenzie S.Q., Au F. The financial impact of advanced kidney disease on Canada Pension Plan and private disability insurance costs. Can J Kidney Health Dis. 2017;4 2054358117703986.
    1. Hill N.R., Fatoba S.T., Oke J.L. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.
    1. Tonelli M., Wiebe N., Culleton B. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047.
    1. Grill A.K., Brimble S. Approach to the detection and management of chronic kidney disease: what primary care providers need to know. Can Fam Physician. 2018;64:728–735.
    1. Alberta Health Services. Kidney Health Strategic Clinical Network. 2016–2019 transformational roadmap. Available at: . Accessed February 7, 2019.
    1. Bello A.K., Levin A., Tonelli M. Assessment of global kidney health care status. JAMA. 2017;317:1864–1881.
    1. The Canadian Society of Nephrology Scientific Committee. Developing a Canadian Research Strategy in Pre-dialysis Chronic Kidney Disease. Montreal, QC, Canada: Canadian Society of Nephrology; 2014.
    1. Birtwhistle R.V. Canadian Primary Care Sentinel Surveillance Network: a developing resource for family medicine and public health. Can Fam Physician. 2011;57:1219–1220.
    1. Bello A.K., Ronksley P.E., Tangri N. A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol. BMJ Open. 2017;7:e016267.
    1. Queenan J.A., Williamson T., Khan S. Representativeness of patients and providers in the Canadian Primary Care Sentinel Surveillance Network: a cross-sectional study. CMAJ Open. 2016;4:E28–E32.
    1. Williamson T., Green M.E., Birtwhistle R. Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records. Ann Fam Med. 2014;12:367–372.
    1. Greiver M., Drummond N., Birtwhistle R. Using EMRs to fuel quality improvement. Can Fam Physician. 2015;61 92–92.
    1. Birtwhistle R., Queenan J.A. Update from CPCSSN. Can Fam Physician. 2016;62:851.
    1. Matsushita K., Mahmoodi B.K., Woodward M. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307:1941–1951.
    1. Ronksley P.E., Tonelli M., Quan H. Validating a case definition for chronic kidney disease using administrative data. Nephrol Dial Transplant. 2012;27:1826–1831.
    1. Denburg M.R., Haynes K., Shults J. Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2011;20:1138–1149.
    1. Pong R.W., DesMeules M., Heng D. Patterns of health services utilization in rural Canada. Chronic Dis Inj Can. 2011;31(Suppl 1):1–36.
    1. Wong S.T., Regan S. Patient perspectives on primary health care in rural communities: effects of geography on access, continuity and efficiency. Rural Remote Health. 2009;9:1142.
    1. Government of Alberta Canadian Deprivation Index. Available at:
    1. Arora P., Vasa P., Brenner D. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ. 2013;185:E417–E423.
    1. Tonelli M., Wiebe N., Straus S. Multimorbidity, dementia and health care in older people: a population-based cohort study. CMAJ Open. 2017;5:E623–E631.
    1. Cheung K.L., Soman S., Tamura M.K. Special considerations in the management of chronic kidney disease in the elderly. Dialysis Transplant. 2011;40:241–243.
    1. Bowling C.B., Plantinga L., Phillips L.S. Association of multimorbidity with mortality and healthcare utilization in chronic kidney disease. J Am Geriatr Soc. 2017;65:704–711.
    1. Mallappallil M., Friedman E.A., Delano B.G. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond) 2014;11:525–535.
    1. Harasemiw O., Milks S., Oakley L. Remote dwelling location is a risk factor for CKD among indigenous Canadians. Kidney Int Rep. 2018;3:825–832.
    1. Laurent S. Rural Canada: Access to Health Care. Ottawa, ON, Canada: Parliamentary Research Branch; 2002.
    1. Herbert R. Canada's health care challenge: recognizing and addressing the health needs of rural Canadians. Lethbridge Undergraduate Research Journal. 2007;2:1–8.
    1. Rucker D., Hemmelgarn B.R., Lin M. Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int. 2011;79:210–217.
    1. McLean G., Guthrie B., Sutton M. Differences in the quality of primary medical care services by remoteness from urban settlements. Qual Saf Health Care. 2007;16:446–449.
    1. Nicholas S.B., Kalantar-Zadeh K., Norris K.C. Socioeconomic disparities in chronic kidney disease. Adv Chronic Kidney Dis. 2015;22:6–15.
    1. Hossain M.P., Goyder E.C., Rigby J.E., El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53:166–174.
    1. Martin D., Miller A.P., Quesnel-Vallee A. Canada's universal health-care system: achieving its potential. Lancet. 2018;391:1718–1735.
    1. Murphy D., McCulloch C.E., Lin F. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165:473–481.
    1. Manns B., Hemmelgarn B., Tonelli M. Population based screening for chronic kidney disease: cost effectiveness study. BMJ. 2010;341:c5869.

Source: PubMed

3
Subscribe